IN.PACT AV Access randomized trial update: 3-year clinical results by anatomic and demographic subsets and 5-year extension mortality analysis
Andrew Holden, Hiroaki Haruguchi, Kotaro Suemitsu, Naoko Isogai et autres
PURPOSE: To report 36-month outcomes by anatomic and demographic subsets, and mortality through 60 months from the IN.PACT AV Access Study, a prospective, multicenter, randomized trial of a paclitaxel drug-coated balloon (DCB) versus percutaneous transluminal angioplasty (PTA) for dysfunctional hemodialysis arteriovenous fistulas …
nz, jp, us, ie (code pays fourni par la source)
0 citations
CVIR Endovascular